Michael Joseph Golembiewski

Insider Reports History

Location
Flemington, NJ
Signature
/s/ Michael Golembiewski
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Joseph Golembiewski:

Company Role Class Num Shares Value Price $ Report Date Ownership
SEELOS THERAPEUTICS, INC. Chief Financial Officer Common Stock 86,869 $95,295 $1.10 29 Feb 2024 Direct
SEELOS THERAPEUTICS, INC. Chief Financial Officer Stock Option (right to buy) 24,537 12 Jan 2024 Direct

Insider Reports Filed by Michael Joseph Golembiewski

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000110465924030070-golembiewski-michael-joseph-2024-02-29 SEELOS THERAPEUTICS, INC. 29 Feb 2024 1 +$457 4 Chief Financial Officer 01 Mar 2024, 17:39
/report/000110465924004596-golembiewski-michael-joseph-2024-01-12 SEELOS THERAPEUTICS, INC. 12 Jan 2024 1 $0 4 Chief Financial Officer 17 Jan 2024, 21:47
/report/000110465923122841-golembiewski-michael-joseph-2023-11-30 SEELOS THERAPEUTICS, INC. 30 Nov 2023 1 +$100,222 4 Chief Financial Officer 01 Dec 2023, 16:16
/report/000110465923097765-golembiewski-michael-joseph-2023-08-31 SEELOS THERAPEUTICS, INC. 31 Aug 2023 1 +$7,725 4 Chief Financial Officer 01 Sep 2023, 16:15
/report/000110465923040289-golembiewski-michael-joseph-2023-03-30 SEELOS THERAPEUTICS, INC. 30 Mar 2023 2 $0 4 Chief Financial Officer 31 Mar 2023, 17:06
/report/000110465923027915-golembiewski-michael-joseph-2023-02-28 SEELOS THERAPEUTICS, INC. 28 Feb 2023 1 +$8,400 4 Chief Financial Officer 02 Mar 2023, 15:06
/report/000113626122000155-golembiewski-michael-joseph-2022-02-28 SEELOS THERAPEUTICS, INC. 28 Feb 2022 1 +$11,262 4 Chief Financial Officer 04 Mar 2022, 15:02
/report/000113626122000041-golembiewski-michael-joseph-2022-01-10 SEELOS THERAPEUTICS, INC. 10 Jan 2022 1 $0 4 Chief Financial Officer 11 Jan 2022, 15:27
/report/000113626121000206-golembiewski-michael-joseph-2021-09-01 SEELOS THERAPEUTICS, INC. 01 Sep 2021 0 $0 3 Chief Financial Officer 02 Sep 2021, 16:03